Delivery Order SPE2DB20D1100-SPE2DB24FC6H9

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price of $12,510.54 and a period of performance through February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $13,022.74 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $6,361.17 firm fixed-price delivery order has a January 2024 award date and an ultimate completion date of January 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a $12,807.48 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the procurement of ENBREL 50 MG/ML SURECLICK. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,878.60 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product. The contract has an ultimate completion date of June 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,153.44, is a delivery order for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $14,476.28 Firm Fixed Price Delivery Order contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication. The contract has a period of performance through February 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order with a ceiling value of $8,563.06 for the supply of the pharmaceutical product ENBREL 50 MG/ML SURECLICKML. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds an...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $66,259.65 for the provision of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,601.23 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, with a period of performance through August 2024. The contract does not have a set-aside designation, indicating it was awarded through open competition....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6H9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The single-award, firm fixed-price delivery order is valued at $10,767.82 and has a period of performance through July 10, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/8/24, 9:16 AM